Skip to content
  • Saturday, 15 August 2026
  • 3:08 am
  • Follow Us
Lab DB
  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ
  • Home
  • Beyond the Gym: The Evolving Science and Therapeutic Potential of Creatine Supplementation
Neuroscience & Brain Research

Beyond the Gym: The Evolving Science and Therapeutic Potential of Creatine Supplementation

Rifan Muazin May 12, 2026 0

Creatine, a nitrogenous organic acid often associated with the high-intensity environment of professional athletics and weightlifting, is currently undergoing a…

Read More
Neuroscience & Brain Research

Beyond the Weight Room: The Evolving Science and Therapeutic Potential of Creatine Supplementation

Rifan Muazin May 4, 2026 0

The scientific understanding of creatine has undergone a significant transformation, moving from its traditional reputation as a niche bodybuilding aid…

Read More
Probiotic Yogurt Strain May Boost Immunotherapy Response in Lung Cancer, Small Study SuggestsA New Vaccine Adjuvant Could Revolutionize Polio Eradication by Inducing Robust Mucosal ImmunityTWiV 1284: Clinical Update with Dr. Daniel GriffinAgentic Workflows to Automate Your Data Science Pipeline
MEDVi Under Scrutiny: AI-Powered Telehealth Startup Faces FDA Warnings, Deceptive Marketing Allegations, and Multiple Lawsuits Despite Meteoric GrowthJapan’s FY26 NHI Drug Price Revision: Deeper Dive into Mechanisms and Market ImpactLLMOps in 2026: The 10 Tools Every Team Must HaveThe Most Favored Nation (MFN) Policy’s Unforeseen Ripple Effect: European Pharmaceutical Launches and Withdrawals Plummet
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’sKing’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid DecompositionSanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
YOU MAY HAVE MISSED
Laboratory Automation & Robotics
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’s
Lana Keisha Jul 25, 2026
Neuroscience & Brain Research
King’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286
Rifan Muazin Jul 25, 2026
Advanced Materials Science
Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid Decomposition
Nila Kartika Wati Jul 25, 2026
Pharmaceutical R&D
Sanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
Teuku Ryan Jul 25, 2026

Copyright © 2025 | Powered by WordPress | News Gadgets by ThemeArile

  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ